The mouse study shows promising results for the long-term administration of low doses of THC.
Get the latest international news and world events from around the world.
Researchers reveal how autism-linked mutation triggers PTSD-like fear
Autism spectrum disorder (ASD) is widely known for its core features, which include difficulties in social communication and repetitive behaviors. But beyond these, many individuals with ASD also struggle with comorbid conditions, particularly anxiety.
Nearly 40% of children with ASD experience anxiety disorders and often show unusually heightened fear responses. Studies have even suggested that people with ASD may be more vulnerable to trauma, unable to “erase” fear memories, which resembles symptoms seen in post-traumatic stress disorder (PTSD).
Until now, most evidence for PTSD-like symptoms in ASD has relied on self-reports, leaving the underlying brain mechanisms unclear.
Anti-ageing and increased mental capacity through cannabis
A low-dose long-term administration of cannabis can not only reverse aging processes in the brain, but also has an anti-aging effect. Researchers from the University Hospital Bonn (UKB) and the University of Bonn together with a team from Hebrew University (Israel) have now been able to show this in mice. They found the key to this in the protein switch mTOR, whose signal strength has an influence on cognitive performance and metabolic processes in the entire organism. The results are now presented in the journal “ACS Pharmacology & Translation Science”
Some of these cookies are necessary and are used to help make our site work. With your consent, we will also use cookies to improve your experience, analyse site usage and assist in our marketing efforts. By clicking ‘Accept all’, you consent to our use of cookies.
Adaptable 3D bioprinting technique can boost engineered tissue output
The field of tissue engineering aims to replicate the structure and function of real biological tissues. This engineered tissue has potential applications in disease modeling, drug discovery, and implantable grafts.
If quantum computing is answering unknowable questions, how do we know they’re right?
Quantum computing promises to solve the seemingly unsolvable in fields such as physics, medicine, cryptography and more.
But as the race to develop the first large-scale, error-free commercial device heats up, it begs the question: how can we check that these ‘impossible’ solutions are correct?
A new Swinburne study is tackling this paradox. The paper is published in the journal Quantum Science and Technology.
